Augmenting Indolent Lymphoma Treatment Options With the Combination of Lenalidomide and Rituximab

J Clin Oncol. 2019 May 10;37(14):1151-1153. doi: 10.1200/JCO.19.00419. Epub 2019 Mar 22.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Lenalidomide
  • Lymphoma, Mantle-Cell*
  • Lymphoma, Non-Hodgkin*
  • Rituximab

Substances

  • Rituximab
  • Lenalidomide